• metastatic/advanced - breast cancer (mBC) 1
• cervical cancer (CC)
• classical Hodgkin lymphoma (cHL)

 

• antibody–drug conjugate
• trastuzumab deruxtecan

• versus all
• vs chemotherapy

• study list
• mapping
• overview
• meta-analysis
• forest plot
• NMA
• excluded

Top evidence (RCT only, high risk of bias excluded) Best available evidence (possibly low or very low) All RCTs All studies (RCT+OBS)

Pathology:  metastatic/advanced - breast cancer (mBC);